14176 Federal Register / Vol. 75, No. 56 / Wednesday, March 24, 2010 / Notices 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; 

Substance Abuse Treatment Referral System 

(5543). 

Date: May 11, 2010. 

Time: 1:30 p.m. to 3 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6101 

Executive Boulevard, Rockville, MD 20852, 

(Telephone Conference Call). 

Contact Person: Lyle Furr, Contract Review 

Specialist, Office of Extramural Affairs, 

National Institute on Drug Abuse, NIH, 

DHHS, Room 220, MSC 8401, 6101 Executive 

Boulevard, Bethesda, MD 20892–8401, (301) 

435–1439, lf33c.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.279, Drug Abuse and 

Addiction Research Programs, National 

Institutes of Health, HHS) 

Dated: March 16, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–6266 Filed 3–23–10; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

National Advisory Council on Drug 

Abuse. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Council on Drug Abuse. 

Date: May 5, 2010. 

Closed: 8:30 a.m. to 10 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852. 

Open: 11 a.m. to 2 p.m. 

Agenda: This portion of the meeting will 

be open to the public for announcements and 

reports of administrative, legislative and 

program developments in the drug abuse 

field. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852. 

Contact Person: Teresa Levitin, PhD, 

Director, Office of Extramural Affairs, 

National Institute on Drug Abuse, NIH, 

DHHS, Room 220, MSC 8401, 6101 Executive 

Boulevard, Bethesda, MD 20892–8401, (301) 

443–2755. 

Any member of the public interested in 

presenting oral comments to the committee 

may notify the Contact Person listed on this 

notice at least 10 days in advance of the 

meeting. Interested individuals and 

representatives of organizations may submit 

a letter of intent, a brief description of the 

organization represented, and a short 

description of the oral presentation. Only one 

representative of an organization may be 

allowed to present oral comments and if 

accepted by the committee, presentations 

may be limited to five minutes. Both printed 

and electronic copies are requested for the 

record. In addition, any interested person 

may file written comments with the 

committee by forwarding their statement to 

the Contact Person listed on this notice. The 

statement should include the name, address, 

telephone number and when applicable, the 

business or professional affiliation of the 

interested person. 

Information is also available on the 

Institutes/Center’s home page: http:// 

www.drugabuse.gov/NACDA/ 

NACDAHome.html, where an agenda and 

any additional information for the meeting 

will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.279, Drug Abuse and 

Addiction Research Programs, National 

Institutes of Health, HHS) 

Dated: March 16, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–6264 Filed 3–23–10; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

Statement of Organization, Functions, 

and Delegations of Authority 

Part F of the Statement of 

Organization, Functions, and 

Delegations of Authority for the 

Department of Health and Human 

Services, Centers for Medicare & 

Medicaid Services (CMS), (Federal 

Register, Vol. 72, No. 248, pp. 73847– 

73850, dated Friday, December 28, 

2007) is amended to reflect changes to 

the current structure of CMS. 

In an effort to improve the value and 

service that CMS provides to the Nation, 

the CMS has modified its structure to 

align similar functions under common 

executive leadership and allow CMS to 

establish a Center for Program Integrity 

and to strengthen its focus on 

beneficiary services and strategic 

planning. 

The structure includes the following, 

which all report to the Administrator, 

CMS: (1) Center for Medicare, (2) Center 

for Medicaid, CHIP and Survey & 

Certification, (3) Center for Strategic 

Planning, (4) Center for Program 

Integrity, and (5) Office of External 

Affairs and Beneficiary Services. In 

addition, the current role of the Chief 

Operating Officer (COO) has been 

formalized and remains responsible for 

operations, information systems, 

contracts, finance, E-health standards 

and services, and the Consortia. The 

COO continues to report to the 

Administrator, CMS. The following 

organizations remain substantively 

unchanged and continue to report to the 

Administrator, CMS: Office of Equal 

Opportunity and Civil Rights, Office of 

Legislation, Office of the Actuary, Office 

of Clinical Standards and Quality, and 

the Office of Strategic Operations and 

Regulatory Affairs (will be renamed the 

Office of Executive Operations and 

Regulatory Affairs to more accurately 

reflect the work of the organization). 

New administrative codes were assigned 

to all organizations, including the 

immediate office of the Administrator. 

Given the complexity and importance 

of CMS’ programs, this realignment of 

existing functions positions CMS to 

consistently excel in serving our 

beneficiaries and strategically positions 

CMS for the future. Additionally, this 

effort ensures common core functions 

are under common executive leadership 

and share a consistent vision. 

The specific amendments to Part F 

are described below: 

I. Under Part F, CMS, Office of the 

Administrator, FA.10 Organization is 

deleted in its entirety and replaced with 

the following: 

FC.10 Organization. CMS is headed 

by the Administrator, CMS, and 

includes the following organizational 

components: 

Office of the Administrator (FC) 

Office of Equal Opportunity and Civil 

Rights (FCA) 


srobinson on DSKHWCL6B1PROD with NOTICES
Federal Register / Vol. 75, No. 56 / Wednesday, March 24, 2010 / Notices 14177 

Office of External Affairs and 

Beneficiary Services (FCB) 

Office of Legislation (FCC) 

Office of the Actuary (FCE) 

Office of Executive Operations and 

Regulatory Affairs (FCF) 

Office of Clinical Standards and Quality 

(FCG) 

Center for Medicare (FCH) 

Center for Medicaid, CHIP and Survey 

& Certification (FCJ) 

Center for Strategic Planning (FCK) 

Center for Program Integrity (FCL) 

Chief Operating Officer (FCM) 

II. Under Part F, CMS, Office of the 

Administrator, FA.20 Functions is 

replaced with FC.20 Functions. The 

functions of the new organizations read 

as follows: 

Office of External Affairs and 

Beneficiary Services (FCB) 

• Serves as CMS’ focal point for 

beneficiary communications and 

services, provides leadership for CMS in 

the areas of intergovernmental affairs, 

and media relations. Advises the 

Administrator and other CMS 

components in all activities related to 

these functions and on matters that 

affect other units and levels of 

government. 

• Contributes to the formulation of 

policies, programs, and systems as well 

as oversees beneficiary services, 

intergovernmental affairs, media 

relations, and tribal affairs, including 

CMS’ Ombudsman program, call center 

operations, web sites, and Medicare 

contractor communications. Coordinates 

with the Office of Legislation on the 

development and advancement of new 

legislative initiatives and 

improvements. 

• Oversees the analysis and 

evaluation of customer data for the 

purpose of improving beneficiary 

communication tools (including but not 

limited to brochures, program/media 

campaigns, handbooks, websites, 

reports, presentations/briefings) and 

identifying best practices for the benefit 

of beneficiaries and other CMS 

customers. Coordinates this data with 

other CMS components to resolve 

customer and beneficiary issues through 

continuous quality improvement. 

• Oversees all CMS interactions and 

collaboration with key stakeholders 

relating to beneficiary communications 

and services, media relations, and 

intergovernmental affairs (e.g., external 

advocacy groups, Medicare beneficiary 

customer service, the media, 

contractors, Native American and 

Alaskan Native tribes, HHS, the White 

House, other CMS components, and 

other Federal government entities). 

• Formulates and implements a 

customer service plan that serves as a 

roadmap for the effective treatment and 

advocacy of customers and the quality 

of information provided to them. 

• Coordinates communications, 

messaging, media relations, partner 

relations and Tribal Affairs outreach 

with the CMS Regional Offices. 

• Serves as senior advisor to the 

Administrator in all activities related to 

the media. Provides consultation, 

advice, and training to CMS’ senior staff 

with respect to relations with the news 

media. 

• Serves as liaison between CMS and 

State and local officials, and individuals 

representing State and local officials 

and advocacy groups. 

• Serves as coordinator of tribal 

affairs issues and liaison between CMS 

and State and local officials 

representing tribal affairs groups. 

Center for Medicare (FCH) 

• Serves as CMS’ focal point for the 

formulation, coordination, integration, 

implementation, and evaluation of 

national Medicare program policies and 

operations. 

• Identifies and proposes 

modifications to Medicare programs and 

policies to reflect changes or trends in 

the health care industry, program 

objectives, and the needs of Medicare 

beneficiaries. Coordinates with the 

Office of Legislation on the 

development and advancement of new 

legislative initiatives and 

improvements. 

• Serves as CMS’ lead for 

management, oversight, budget and 

performance issues relating to Medicare 

Advantage and prescription drug plans, 

Medicare fee-for-service providers and 

contractors. 

• Oversees all CMS interactions and 

collaboration with key stakeholders 

relating to Medicare (e.g., plans, 

providers, other government entities, 

advocacy groups, Consortia) and 

communication and dissemination of 

policies, guidance and materials to same 

to understand their perspectives and to 

drive best practices in the health care 

industry. 

• Develops and implements a 

comprehensive strategic plan, objectives 

and measures to carry out CMS’ 

Medicare program mission and goals 

and position the organization to meet 

future challenges with the Medicare 

program and its beneficiaries. 

• Coordinates with the Center for 

Program Integrity on the identification 

of program vulnerabilities and 

implementation of strategies to 

eliminate fraud, waste, and abuse. 

Center for Medicaid, CHIP and Survey 

& Certification (FCJ) 

• Serves as CMS’ focal point for the 

formulation, coordination, integration, 

implementation, and evaluation of all 

national program policies and 

operations relating to Medicaid, CHIP, 

Survey & Certification, and the Clinical 

Laboratory Improvement Act (CLIA). 

• In partnership with States, 

evaluates the success of State agencies 

in carrying out their responsibilities for 

effective State program administration 

and beneficiary protection, and, as 

necessary, assists States in correcting 

problems and improving the quality of 

their operations. 

• Identifies and proposes 

modifications to Medicaid and CHIP 

program measures, regulations, laws 

and policies to reflect changes or trends 

in the health care industry, program 

objectives, and the needs of Medicaid 

and CHIP beneficiaries. Collaborates 

with the Office of Legislation on the 

development and advancement of new 

legislative initiatives and 

improvements. 

• Oversees the planning, coordination 

and implementation of the survey, 

certification and enforcement programs 

for all Medicare and Medicaid providers 

and suppliers, and for laboratories 

under the auspices of CLIA. 

• Serves as CMS’ lead for 

management, oversight, budget and 

performance issues relating to Medicaid, 

CHIP and Survey and Certification, and 

the related interactions with the States. 

• Coordinates with the Center for 

Program Integrity on the identification 

of program vulnerabilities and 

implementation of strategies to 

eliminate fraud, waste, and abuse. 

• In conjunction with the Office of 

External Affairs, oversees all CMS 

interactions and collaboration relating 

to Medicaid and CHIP with 

beneficiaries, States and territories and 

key stakeholders (i.e., health facilities 

and other health care providers, other 

Federal government entities, local 

governments) and communication and 

dissemination of policies, guidance and 

materials to same to understand their 

perspectives, support their efforts, and 

to drive best practices for beneficiaries, 

in States and throughout the health care 

industry. 

• Develops and implements a 

comprehensive strategic plan, objectives 

and measures to carry out CMS’ 

Medicaid and CHIP mission and goals 

and position the organization to meet 

future challenges with the Medicaid, 

CHIP and Survey & Certification, and 

CLIA programs. 


srobinson on DSKHWCL6B1PROD with NOTICES
14178 Federal Register / Vol. 75, No. 56 / Wednesday, March 24, 2010 / Notices 

Center for Strategic Planning (FCK) 

• Serves as CMS’ focal point for the 

planning, formulation and coordination 

of long-term strategic plans, and future 

program policy and proposals for CMS. 

• Collaborates with the Office of 

Legislation on the development and 

advancement of new legislative 

initiatives and improvements. 

• Conducts environmental scanning, 

identifying, evaluating and reporting 

emerging trends in health care delivery 

and financing and their interactions 

with CMS programs and implications 

for future policy development and 

planning. 

• Oversees strategic, cross-cutting 

initiatives in coordination with other 

CMS components and external 

stakeholders. 

• In collaboration with other CMS 

components, designs, coordinates, 

conducts research, demonstrations, 

analyses and special studies, and 

evaluates the results for impacts on 

beneficiaries, providers, plans, health 

care programs and financing, States and 

other partners, designing and assessing 

potential improvements, and developing 

new measurement tools. 

• Oversees the development and 

dissemination of publications, data 

analyses, graphics, and briefing 

materials related to health care issues. 

Center for Program Integrity (FCL) 

• Serves as CMS’ focal point for all 

national and State-wide Medicare and 

Medicaid programs and CHIP integrity 

fraud and abuse issues. 

• Promotes the integrity of the 

Medicare and Medicaid programs and 

CHIP through provider/contractor audits 

and policy reviews, identification and 

monitoring of program vulnerabilities, 

and providing support and assistance to 

States. Recommends modifications to 

programs and operations as necessary 

and works with CMS Centers and 

Offices to affect changes as appropriate. 

Collaborates with the Office of 

Legislation on the development and 

advancement of new legislative 

initiatives and improvements to deter, 

reduce, and eliminate fraud, waste and 

abuse. 

• Oversees all CMS interactions and 

collaboration with key stakeholders 

relating to program integrity (i.e., U.S. 

Department of Justice, HHS Office of 

Inspector General, State law 

enforcement agencies, other Federal 

entities, CMS components) for the 

purposes of detecting, deterring, 

monitoring and combating fraud and 

abuse, as well as taking action against 

those that commit or participate in 

fraudulent or other unlawful activities. 

• In collaboration with other CMS 

Centers and Offices, develops and 

implements a comprehensive strategic 

plan, objectives and measures to carry 

out CMS’ Medicare, Medicaid and CHIP 

program integrity mission and goals, 

and ensure program vulnerabilities are 

identified and resolved. 

Chief Operating Officer (FCM) 

• Overall responsibility for 

facilitating the coordination, integration 

and execution of CMS policies and 

activities across CMS components, 

including new program initiatives. 

• Promotes accountability, 

communication, coordination, and 

facilitation of cooperative corporate 

decision-making among CMS senior 

leadership on management, operational 

and programmatic cross-cutting issues. 

• Tracks and monitors CMS 

performance and intervenes, as 

appropriate, to ensure key milestones/ 

deliverables are successfully achieved. 

Keeps the Administrator and Principal 

Deputy Administrator advised of the 

status of significant national initiatives 

and programs that affect beneficiaries 

and/or the health care industry and 

makes recommendations regarding 

necessary corrective actions. 

• Provides executive leadership to 

CMS’ Consortia operations, including 

facilitating all required interaction and 

coordination between Consortia and 

other CMS components. 

• Oversees all planning, 

implementation and evaluation of 

administrative and operational activities 

for CMS, including enterprise-wide 

information systems and services, 

acquisition and grants, financial 

management, electronic health 

standards, facilities, and human 

resources. 

Delegations of Authority 

All delegations and re-delegations of 

authority made to officials and 

employees of affected organizational 

components will continue in them or 

their successor organization pending 

further re-delegation, provided they are 

consistent with this realignment. 

(Authority: 44 U.S.C. 3101) 

Dated: March 18, 2010. 

Kathleen Sebelius, 

Secretary. 

[FR Doc. 2010–6429 Filed 3–23–10; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Statement of Organization, Functions, 

and Delegations of Authority 

Part C (Centers for Disease Control 

and Prevention) of the Statement of 

Organization Functions, and 

Delegations of Authority of the 

Department of Health and Human 

Services (45 FR 67772–76, dated 

October 14, 1980, and corrected at 45 FR 

69296, October 20, 1980, as amended 

most recently at 75 FR 10296, dated 

March 5, 2010) is amended to reflect the 

reorganization of the Office of Dispute 

Resolution and Equal Opportunity 

Office, Office of the Director, Centers for 

Disease Control and Prevention. 

Section C–B, Organization and 

Functions, is hereby amended as 

follows: Delete in its entirety the title 

and functional statement for the Office 

of Dispute Resolution and Equal 

Opportunity Office (CAV) and insert the 

following: 

Office of Diversity Management and Equal 

Employment Opportunity (CAV). The Office 

of Diversity Management and Equal 

Employment Opportunity (ODMEEO) is 

located in the Office of the Director, Centers 

for Disease Control and Prevention (CDC). 

The Director, ODMEEO serves as the 

principal advisor to the Director, CDC, on all 

equal employment opportunity matters. The 

mission of the ODMEEO is to ensure an 

environment that promotes equal 

employment opportunity and diversity for all 

individuals, eradicates discrimination and 

harassment in all forms, and promotes an 

inclusive environment and values diversity 

that empowers employees to participate and 

support CDC’s global health mission. In 

carrying out its mission the ODMEEO: (1) 

Develops and recommends for adoption CDCwide equal employment opportunity 

policies, goals, and priorities to carry out the 

directives of the U.S. Office of Personnel 

Management, U.S. Equal Employment 

Opportunity Commission, and Department of 

Health and Human Services (DHHS) equal 

employment opportunity policies and 

requirements that are mandated by Title VII, 

Civil Rights Act of 1964; Age Discrimination 

in Employment Act (ADEA); Rehabilitation 

Act of 1973; Civil Service Reform Act; 29 

CFR 1614, Federal Sector Equal Employment 

Opportunity; Executive Order 11478, Equal 

Employment Opportunity in the Federal 

Government; (2) provides leadership, 

direction, and technical guidance to CDC 

managers and staff for the development of 

comprehensive programs and plans; (3) 

coordinates and evaluates agency equal 

employment opportunity operations and 

plans, including affirmative action; (4) 

develops plans, programs, and procedures to 

assure the prompt receipt, investigation, and 

resolution of complaints of alleged 


srobinson on DSKHWCL6B1PROD with NOTICES